Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine

Vaccine

Volumn 25, Issue 49, 2007, Pages 8228-8240

  Greco, Raffaella ^a   Michel, Marie ^b   Guetard, Denise ^b   Cervantes Gonzalez, Minerva ^b   Pelucchi, Nilla ^a   Wain Hobson, Simon ^b   Sala, Francesco ^a   Sala, Monica ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUT PASTEUR   (France)

Author keywords

Bivalent vaccine; HBV; HIV 1; Transgenic plants; VLPs

Indexed keywords

HYBRID PROTEIN; VACCINE;

ANTIBODY RESPONSE; ARABIDOPSIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INGESTION; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TOBACCO; TRANSGENIC PLANT; VIRUS LIKE AGENT; VIRUS REPLICATION; VIRUS TRANSMISSION;

AIDS VACCINES; ARABIDOPSIS; CELL LINE, TUMOR; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT FUSION PROTEINS; TOBACCO; TRANSGENES; VIRAL PROTEINS;

EID: 36049019911     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.061     Document Type: Article

References (48)

1. Siliciano R.F. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution. Top HIV Med 13 3 (2005) 96-100
2. Belyakov I.M., Hel Z., Kelsall B., Kuznetsov V.A., Ahlers J.D., Nacsa J., et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med 7 12 (2001) 1320-1326
3. + CTLs in delay of AIDS viral dissemination from mucosa. Blood 107 8 (2006) 3258-3264
4. Grgacic E.V., and Anderson D.A. Virus-like particles: passport to immune recognition. Methods 40 1 (2006) 60-65
5. Huang Z., Santi L., LePore K., Kilbourne J., Arntzen C.J., and Mason H.S. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 24 14 (2006) 2506-2513
6. Franconi R.D.B.P., Dibello F., Accardi L., Muller A., Cirilli A., Simeone P., et al. Plant-derived papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection. Cancer Res 62 (2002) 3654-3658
7. Kapusta J., Modelska A., Figlerowicz M., Pniewski T., Letellier M., Lisowa O., et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J 13 13 (1999) 1796-1799
8. Kim T.G., Gruber A., Ruprecht R.M., and Langridge W.H. Synthesis and assembly of SIVmac Gag p27 capsid protein cholera toxin B subunit fusion protein in transgenic potato. Mol Biotechnol 28 1 (2004) 33-40
9. Perez-Filgueira D.M., Brayfield B.P., Phiri S., Borca M.V., Wood C., and Morris T.J. Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector. J Virol Methods 121 2 (2004) 201-208
10. Zhang X., Buehner N.A., Hutson A.M., Estes M.K., and Mason H.S. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J 4 4 (2006) 419-432
11. Sala F., Rigano M.M., Barbante A., Basso B., Walmsley A.M., and Castiglione S. Vaccine antigene production in transgenic plants: strategies, gene constructs and perspectives. Vaccine 21 (2003) 803-808
12. Thanavala Y., Huang Z., and Mason H.S. Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead. Expert Rev Vaccines 5 2 (2006) 249-260
13. Kapusta J., Modelska A., Pniewski T., Figlerowicz M., Jankowski K., Lisowa O., et al. Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Adv Exp Med Biol 495 (2001) 299-303
14. Kong Q., Richter L., Yang Y.F., Arntzen C.J., Mason H.S., and Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 98 20 (2001) 11539-11544
15. Obregon P., Chargelegue D., Drake P.M., Prada A., Nuttall J., Frigerio L., et al. HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnol J 4 2 (2006) 195-207
16. Zhang G.G., Rodrigues L., Rovinski B., and White K.A. Production of HIV-1 p24 protein in transgenic tobacco plants. Mol Biotechnol 20 2 (2002) 131-136
17. Marusic C., Nuttall J., Buriani G., Lico C., Lombardi R., Baschieri S., et al. Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells. BMC Biotechnol 7 (2007) 12
18. Karasev A.V., Foulke S., Wellens C., Rich A., Shon K.J., Zwierzynski I., et al. Plant-based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine 23 15 (2005) 1875-1880
19. Shchelkunov S.N., Salyaev R.K., Pozdnyakov S.G., Rekoslavskaya N.I., Nesterov A.E., Ryzhova T.S., et al. Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnol Lett 28 13 (2006) 959-967
20. + T-cell response in HIV infection. AIDS Rev 6 2 (2004) 79-88
21. + T-cell responses are involved in durable control of AIDS virus replication. J Virol 81 7 (2007) 3465-3476
22. Saez-Cirion A., Lacabaratz C., Lambotte O., Versmisse P., Urrutia A., Boufassa F., et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 104 16 (2007) 6776-6781
23. Girard M.P., Osmanov S.K., and Kieny M.P. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 24 19 (2006) 4062-4081
24. Michel M., Lone Y.C., Centlivre M., Roux P., Wain-Hobson S., and Sala M. Optimisation of secretion of recombinant HBsAg virus-like particles: impact on the development of HIV-1/HBV bivalent vaccines. Vaccine 25 (2007) 1901-1911
25. Firat H., Garcia-Pons F., Tourdot S., Pascolo S., Scardino A., Garcia Z., et al. H-2 class I knockout, HLA-A2. 1 transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur J Immunol 29 10 (1999) 3112-3121
26. Pajot A., Michel M.L., Fazilleau N., Pancre V., Auriault C., Ojcius D.M., et al. A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice. Eur J Immunol 34 11 (2004) 3060-3069
27. Xu J.Q., Wang J.J., Han L.F., Xu C., Ruan Y.H., Xu Z.H., et al. Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China. Chin Med J (Engl) 119 23 (2006) 1941-1948
28. Gatanaga H., Ibe S., Matsuda M., Yoshida S., Asagi T., Kondo M., et al. Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan. Antiviral Res (2006)
29. Konopnicki D., Mocroft A., de Wit S., Antunes F., Ledergerber B., Katlama C., et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. Aids 19 6 (2005) 593-601
30. Sucupira M.V., Mello F.C., Santos E.A., Niel C., Rolla V.C., Arabe J., et al. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem Inst Oswaldo Cruz 101 6 (2006) 655-660
31. Chung R.T. Hepatitis C and B viruses: the new opportunists in HIV infection. Top HIV Med 14 2 (2006) 78-83
32. Feld J.J., Ocama P., and Ronald A. The liver in HIV in Africa. Antivir Ther 10 8 (2005) 953-965
33. Le Borgne S., Mancini M., Le Grand R., Schleef M., Dormont D., Tiollais P., et al. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology 240 2 (1998) 304-315
34. Marsac D., Puaux A.-L., Riviere Y., and Michel M.L. In vivo induction of cellular and humoral immune response by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice. Immunobiology 210 5 (2005) 305-319
35. Michel M.L., Davis H.L., Schleef M., Mancini M., Tiollais P., and Whalen R.G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 92 12 (1995) 5307-5311
36. Kyte J., and Doolittle R. A simple method for displaying the hydropathic character of a protein. J Mol Biol 157 (1982) 105-132
37. Horsch R.B., Fry J.E., Hoffmann N.L., Eichholtz D., Rogers S.G., and Fraley R.T. A simple and general method for transferring genes into plants. Science 227 (1985) 1129-1231
38. Clough S.J., and Bent A.F. Floral dip: a simplified method for Agrobacterium-mediated transformation of Arabidopsis thaliana. Plant J 16 6 (1998) 735-743
39. Murashige T., and Skooog F. A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol Plant 15 (1962) 493-497
40. Greco R., Ouwerkerk P.B., Taal A.J., Favalli C., Beguiristain T., Puigdomenech P., et al. Early and multiple Ac transpositions in rice suitable for efficient insertional mutagenesis. Plant Mol Biol 46 2 (2001) 215-227
41. Huang Z., Elkin G., Maloney B.J., Beuhner N., Arntzen C.J., Thanavala Y., et al. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 23 15 (2005) 1851-1858
42. Greco R., Ouwerkerk P.B.F., Taal A.J.C., Sallaud C., Guiderdoni E., Meijer A.H., et al. Transcription and somatic transposition of the maize En/Spm transposon system in rice. Mol Genet Genomics 270 6 (2004) 514-523
43. Jones J., Krag S.S., and Betenbaugh M.J. Controlling N-linked glycan site occupancy. Biochim Biophys Acta 1726 2 (2005) 121-137
44. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J 16 9 (1997) 2482-2492
45. Boisgerault F., Moron G., and Leclerc C. Virus-like particles: a new family of delivery systems. Expert Rev Vaccines 1 1 (2002) 101-109
46. Smith M.L., Richter L., Arntzen C.J., Shuler M.L., and Mason H.S. Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine 21 25-26 (2003) 4011-4021
47. Huang Z., and Mason H.S. Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system. Plant Biotechnol J 2 3 (2004) 241-249
48. Chen Q.J., Zhou H.M., Chen J., and Wang X.C. A Gateway-based platform for multigene plant transformation. Plant Mol Biol 62 6 (2006) 927-936